다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of advanced research, v.1 no.3, 2010년, pp.169 - 177
Gad, M.Z. (Department of Biochemistry, Faculty of Pharmacy and Biotechnology, The German University in Cairo - GUC, Main Entrance Al Tagamoa Al Khames, New Cairo City 11835, Egypt)
AI-Helper
l-Arginine is one of the most metabolically versatile amino acids. In addition to its role in the synthesis of nitric oxide, l-arginine serves as a precursor for the synthesis of polyamines, proline, glutamate, creatine, agmatine and urea. Several human and experimental animal studies have indicated...
Z Physiol Chem Hedin 21 297 1895 10.1515/bchm2.1896.21.4.297 Eine methods das lysin zu isolieren, nebst einigen Bemerkungen uber das lysatinin
Am J Clin Nutr Morris 83 2 508S 2006 10.1093/ajcn/83.2.508S Arginine: beyond protein
Am J Physiol Dhanakoti 259 3 Pt 1 E437 1990 Renal arginine synthesis: studies in vitro and in vivo
Essays Biochem Watford 26 49 1991 The urea cycle: a two-compartment system
Biochim Biophys Acta White 822 3-4 355 1985 10.1016/0304-4157(85)90015-2 The transport of cationic amino acids across the plasma membrane of mammalian cells
J Clin Invest Kamada 108 5 717 2001 10.1172/JCI200111260 Vascular endothelial dysfunction resulting from l-arginine deficiency in a patient with lysinuric protein intolerance
Am J Physiol Renal Physiol Kone 285 2 F178 2003 10.1152/ajprenal.00048.2003 Protein interactions with nitric oxide synthases: controlling the right time, the right place and the right amount of nitric oxide
Annu Rev Pharmacol Toxicol Boger 41 79 2001 10.1146/annurev.pharmtox.41.1.79 The clinical pharmacology of l-arginine
Vasc Med Maxwell 5 1 11 2000 Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBarReg
J Hypertens Watanabe 18 2 229 2000 10.1097/00004872-200018020-00015 Effects of oral administration of l-arginine on renal function in patients with heart failure
Ann Intern Med Schwartz 138 2 160 2003 10.7326/0003-4819-138-2-200301210-00027 Amelioration of microvascular angina with arginine supplementation
J Am Coll Cardiol Wolf 29 3 479 1997 10.1016/S0735-1097(97)00523-8 Dietary l-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans
J Parent Enteral Nutr Hurson 19 3 227 1995 10.1177/0148607195019003227 Metabolic effects of arginine in a healthy elderly population
Arterioscler Thromb Tarry 14 6 938 1994 10.1161/01.ATV.14.6.938 l-Arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty
Cardiovasc Res Okazaki 36 3 429 1997 10.1016/S0008-6363(97)00188-0 l-Arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholesterolemic rabbits
Altern Med Rev Boger 10 1 14 2005 l-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor
Kidney Blood Pres Res El Mesallamy 31 3 189 2008 10.1159/000135655 Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by l-arginine intake
Circulation Cooke 83 3 1057 1991 10.1161/01.CIR.83.3.1057 Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta
Circulation Tsao 89 5 2176 1994 10.1161/01.CIR.89.5.2176 Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by l-arginine
Cardiovasc Res Bode Boger 37 3 756 1998 10.1016/S0008-6363(97)00295-2 Chronic dietary supplementation with l-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo
Atherosclerosis Boger 136 1 67 1998 10.1016/S0021-9150(97)00183-4 Dietary l-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits
Curr Opin Nephrol Hypertens Maxwell 7 1 63 1998 10.1097/00041552-199801000-00011 Cardiovascular effects of l-arginine
Lancet Drexler 338 8782-8783 1546 1991 10.1016/0140-6736(91)92372-9 Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by l-arginine
J Clin Endocrinol Metab Higashi 80 7 2198 1995 Intravenous administration of l-arginine inhibits angiotensin-converting enzyme in humans
Thromb Res Udvardy 87 1 75 1997 10.1016/S0049-3848(97)00106-0 Effect of l-arginine on in vitro plasmin-generation and fibrinogenolysis
Biochem Biophys Res Commun Walter 269 3 687 2000 10.1006/bbrc.2000.2344 Pharmacological concentrations of arginine influence human whole blood viscosity independent of nitric oxide synthase activity in vitro
Life Sci Brandes 66 16 1519 2000 10.1016/S0024-3205(00)00469-0 l-Arginine supplementation in hypercholesterolemic rabbits normalizes leukocyte adhesion to non-endothelial matrix
Clin Nutr Yin 24 6 988 2005 10.1016/j.clnu.2005.07.003 l-Arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease
Trans Assoc Am Physicians Holt 58 143 1944 Observations on amino acid deficiencies in man
Bull Osaka Med Sch Tanimura 13 2 84 1967 Studies on arginine in human semen. II. The effects of medication with l-arginine-HCL on male infertility
BJU Int Chen 83 3 269 1999 10.1046/j.1464-410x.1999.00906.x Effect of oral administration of high-dose nitric oxide donor l-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study
J Urol Moody 158 3 Pt 1 942 1997 10.1016/S0022-5347(01)64368-4 Effects of long-term oral administration of l-arginine on the rat erectile response
J Urol Melman 158 3 Pt 1 686 1997 10.1097/00005392-199709000-00002 This month in investigative urology. l-Arginine and penile erection
Int J Impot Res Zorgniotti 6 1 33 1994 Effect of large doses of the nitric oxide precursor, l-arginine, on erectile dysfunction
Urol Int Klotz 63 4 220 1999 10.1159/000030454 Effectiveness of oral l-arginine in first-line treatment of erectile dysfunction in a controlled crossover study
Pharmacol Ther Toda 106 2 233 2005 10.1016/j.pharmthera.2004.11.011 Nitric oxide and penile erectile function
Br J Pharmacol Lopez Belmonte 108 1 73 1993 10.1111/j.1476-5381.1993.tb13442.x The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa
Br J Pharmacol Calatayud 127 5 1111 1999 10.1038/sj.bjp.0702649 Mechanisms of gastroprotection by transdermal nitroglycerin in the rat
Eur J Pharmacol Pique 174 2-3 293 1989 10.1016/0014-2999(89)90324-5 The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation
Gastroenterology Pique 102 1 168 1992 10.1016/0016-5085(92)91797-8 Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion
Proc Natl Acad Sci USA Kubes 88 11 4651 1991 10.1073/pnas.88.11.4651 Nitric oxide: an endogenous modulator of leukocyte adhesion
Gastroenterology Wallace 112 3 1000 1997 10.1053/gast.1997.v112.pm9041264 Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years
Proc Natl Acad Sci USA Salvemini 90 15 7240 1993 10.1073/pnas.90.15.7240 Nitric oxide activates cyclooxygenase enzymes
Pharmacol Res Khattab 43 5 463 2001 10.1006/phrs.2001.0801 Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion
J Gastroenterol Lazaratos 30 5 578 1995 10.1007/BF02367782 l-Arginine and endogenous nitric oxide protect the gastric mucosa from endothelin-1-induced gastric ulcers in rats
Dig Dis Sci Jimenez 47 1 44 2002 10.1023/A:1013203217788 Mechanisms involved in protection afforded by l-arginine in ibuprofen-induced gastric damage: role of nitric oxide and prostaglandins
Eur J Pharmacol Konturek 239 1-3 215 1993 10.1016/0014-2999(93)90997-V Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers
Am J Physiol Hogaboam 268 4 Pt 1 G673 1995 The selective beneficial effects of nitric oxide inhibition in experimental colitis
Dig Dis Sci Yamamoto 29 5 394 1984 10.1007/BF01296212 Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats
Digestion Brzozowski 56 6 463 1995 10.1159/000201277 Healing of chronic gastric ulcerations by l-arginine. Role of nitric oxide, prostaglandins, gastrin and polyamines
Nitric Oxide Schwentker 7 1 1 2002 10.1016/S1089-8603(02)00002-2 Nitric oxide and wound repair: role of cytokines?
Surgery Seifter 84 2 224 1978 Arginine: an essential amino acid for injured rats
Surgery Kirk 114 2 155 1993 Arginine stimulates wound healing and immune function in elderly human beings
Life Sci Arbss 67 20 2493 2000 10.1016/S0024-3205(00)00836-5 Early effects of exogenous arginine after the implantation of prosthetic material into the rat abdominal wall
J Immunol Albina 144 10 3877 1990 10.4049/jimmunol.144.10.3877 Temporal expression of different pathways of l-arginine metabolism in healing wounds
Surgery Shi 128 2 374 2000 10.1067/msy.2000.107372 Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice
Eur Surg Res Angele 34 1-2 53 2002 10.1159/000048888 l-Arginine: a unique amino acid for improving depressed wound immune function following hemorrhage
Chin Med J (Engl) Chen 112 9 828 1999 Dose-effect of dietary l-arginine supplementation on burn wound healing in rats
Am J Physiol Endocrinol Metab Yu 280 3 E509 2001 10.1152/ajpendo.2001.280.3.E509 Arginine and ornithine kinetics in severely burned patients: increased rate of arginine disposal
Eur J Pharmacol Pieper 317 2-3 317 1996 10.1016/S0014-2999(96)00831-X Short-term oral administration of l-arginine reverses defective endothelium-dependent relaxation and cGMP generation in diabetes
Am J Cardiol Abbasi 88 10 1201 2001 10.1016/S0002-9149(01)02063-X Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus
Am J Physiol Giugliano 273 3 Pt 1 E606 1997 l-Arginine for testing endothelium-dependent vascular functions in health and disease
Eur J Clin Invest Wascher 27 8 690 1997 10.1046/j.1365-2362.1997.1730718.x Effects of low-dose l-arginine on insulin-mediated vasodilatation and insulin sensitivity
Free Radic Biol Med Lubec 22 1-2 355 1997 10.1016/S0891-5849(96)00386-3 l-Arginine reduces lipid peroxidation in patients with diabetes mellitus
Diabetes Care Piatti 24 5 875 2001 10.2337/diacare.24.5.875 Long-term oral l-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients
Science Schmidt 255 5045 721 1992 10.1126/science.1371193 Insulin secretion from pancreatic B cells caused by l-arginine-derived nitrogen oxides
Eur J Endocrinol Thams 140 1 87 1999 10.1530/eje.0.1400087 l-Arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide
Eur J Pharmacol Bohme 199 3 379 1991 10.1016/0014-2999(91)90505-K Possible involvement of nitric oxide in long-term potentiation
N Engl J Med Moncada 329 27 2002 1993 10.1056/NEJM199312303292706 The l-arginine-nitric oxide pathway
Neuroreport Chapman 3 7 567 1992 10.1097/00001756-199207000-00005 Inhibition of nitric oxide synthesis impairs two different forms of learning
Am J Med Ohtsuka 108 5 439 2000 10.1016/S0002-9343(99)00396-4 Effect of oral administration of l-arginine on senile dementia
Int J Clin Exp Pathol Yi 2 3 211 2009 l-Arginine and Alzheimer's disase
J Int Soc Sports Nutr Campbell 1 2 35 2004 10.1186/1550-2783-1-2-35 The ergogenic potential of arginine
Schweiz Z Sportmed Gremion 37 4 241 1989 Aspartate d’arginine et activite musculaire. Partie II [Arginine aspartate and muscular activity. II]
Rev Bras Med Esporte Angeli 13 2 129 2007 10.1590/S1517-86922007000200012 Investigação dos efeitos da suplementação oral de arginina no aumento de força e massa muscular [Investigation of the effects of oral supplementation of arginine in the increase of muscular strength and mass]
Am J Pathol Hnia 172 6 1509 2008 10.2353/ajpath.2008.071009 l-Arginine decreases inflammation and modulates the nuclear factor-κB/matrix metalloproteinase cascade in Mdx muscle fibers
Neurobiol Dis Chaubourt 6 6 499 1999 10.1006/nbdi.1999.0256 Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy
Diabetes Care Fossel 27 1 284 2004 10.2337/diacare.27.1.284 Improvement of temperature and flow in feet of subjects with diabetes with use of a transdermal preparation of l-arginine: a pilot study
Semin Nephrol Klahr 19 3 304 1999 Can l-arginine manipulation reduce renal disease?
Lancet Park 337 8742 645 1991 10.1016/0140-6736(91)92456-C Stimulation of lymphocyte natural cytotoxicity by l-arginine
Evid Based Compl Altern Med Gupta 2 1 93 2005 10.1093/ecam/neh054 Anti-stress and adaptogenic activity of l-arginine supplementation
Growth Horm IGF Res Collier 15 2 136 2005 10.1016/j.ghir.2004.12.004 Growth hormone responses to varying doses of oral arginine
Atherosclerosis Boger 117 2 273 1995 10.1016/0021-9150(95)05582-H Supplementation of hypercholesterolaemic rabbits with l-arginine reduces the vascular release of superoxide anions and restores NO production
Am J Respir Crit Care Med Grasemann 174 2 208 2006 10.1164/rccm.200509-1439OC Inhaled l-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis
Hendler 248 2001 PDR for nutritional supplements l-Arginine
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.